{"id":196613,"name":"SAREPTA THERAPEUTICS","slug":"sarepta-therapeutics","state":"MA","country":"United States of America","description":"A biopharmaceutical company.","totalSpending":800000,"filings":18,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":200000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["FORBES-TATE"],"lobbyists":["ZACHARY WILLIAMS","ELIZABETH GREER","EDWARD RENO","DERRICK WHITE","CYNTHIA BROWN","KRISTINA DUNKLIN","FRANCESCA MCCRARY","KELLEY WILLIAMS","BARRETT THORNHILL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to medicare and Medicaid reimbursement, issues related to rare diseases.","Issues related to medicare and Medicaid reimbursement, issues related to rare diseases.","Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases.","Issues related to Medicare and Medicaid reimbursement; Issues related to rare disease.","Issues related to Medicare and Medicaid reimbursement; Issues related to rare disease."]}